Debios Diagnostics
Debios Diagnostics
Claim
Debios Diagnostics is developing FIBROKIT®, a patented, industrialised pre-market urine-based IVD platform for non-invasive kidney fibrosis assessment. Fibrosis is a key driver of CKD progression and a major unmet need across the cardio-renal-metabolic axis. Advancing clinical validation and IVDR certification, FIBROKIT® can support pharma R&D through patient stratification, longitudinal monitoring and clinical trial enrichment.Debios Diagnostics is developing FIBROKIT®, a patented, industrialised pre-market urine-based IVD p Show More
Alpha Score
Alpha Score
36.0
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0